Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Can-Fite Biopharma Ltd (NY: CANF)
2.470 USD  +0.010 (+0.41%)
Streaming Delayed Price  /  Updated: 1:07 PM EDT, Aug 4, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 352,033
Open 2.460
Bid (Size) 2.470 (1)
Ask (Size) 2.480 (5)
Prev. Close 2.460
Today's Range 2.434 - 2.540
52wk Range 1.080 - 4.950
Shares Outstanding 19,981,145
Dividend Yield N/A
Performance
YTD
-20.83%
-20.83%
1 Month
+41.14%
+41.14%
3 Month
+38.76%
+38.76%
6 Month
+16.51%
+16.51%
1 Year
-7.14%
-7.14%
Top News
More News
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study Read More
from Business Wire News Releases
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds
Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds Read More
from Business Wire News Releases
More News
Read More
Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles
from PR Newswire
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
from Business Wire News Releases
Can-Fite Announces $3.4 Million Registered Direct Offering
from Business Wire News Releases
Can-Fite Announces Final Data Analysis from Phase II NASH Study: Highly Significant and Sustained Reduction in Liver Fat Volume Throughout Study Period
from Business Wire News Releases
Can-Fite Announces $8.0 Million Registered Direct Offering
from Business Wire News Releases
Following Pre-IND Guidance from FDA Can-Fite to Advance Piclidenoson into Phase II COVID-19 Trial in the U.S.
from Business Wire News Releases
Thinking about buying stock in Can Fite Biopharma, RTI Surgical Holdings, JetBlue Airways, iBio Inc, or Sunrun Inc?
from PR Newswire
Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.